News AbbVie waits on data from Humira successor Ablynx's vobarilizumab seen as key should Humira sales fall.
News Imbruvica granted fourth Breakthrough status The drug is also granted Orphan Drug Designation by the FDA.
News Novartis cancer drugs among raft of NICE recommendations NICE recommends funding for lung cancer and skin cancer treatments.
News Isomorphic adds MSD to partner roster, and other deals It's been a busy dealmaking week, with Isomorphic Labs, fresh from a $5 billion financing, adding MSD to its list of research alliances.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.